LEASE TERMINATION AGREEMENT [FOURTH AND VINE]Lease Termination Agreement • March 8th, 2018 • Cascadian Therapeutics, Inc. • Services-commercial physical & biological research • Washington
Contract Type FiledMarch 8th, 2018 Company Industry JurisdictionThis Lease Termination Agreement (this “Agreement”) is entered into as of the 4th day of December 2017, by and between Selig Holdings Company, a Washington limited liability company (“Landlord”) and Cascadian Therapeutics, Inc., a Delaware corporation (“Tenant”), formerly known as Oncothyreon Inc.
3101 WESTERN AVENUE SEATTLE, WASHINGTON SUBLEASE by and between CTI BIOPHARMA, CORP., a Washington corporation as SUBLANDLORD and CASCADIAN THERAPEUTICS, INC., a Delaware corporation as SUBTENANTSublease • March 8th, 2018 • Cascadian Therapeutics, Inc. • Services-commercial physical & biological research • Washington
Contract Type FiledMarch 8th, 2018 Company Industry JurisdictionThis SUBLEASE (this “Sublease”) is entered into as of the Effective Date, by and between CTI BIOPHARMA, CORP., a Washington corporation (“Sublandlord”), and CASCADIAN THERAPEUTICS, INC., a Delaware corporation (“Subtenant”), with reference to the following Recitals.